OCT 23, 2019 11:19 PM PDT

Treating Gulf-War Illness with Anti-Viral Drugs

WRITTEN BY: Nouran Amin

Researchers at the University of South Carolina's Arnold School of Public Health have reported that repurposing existing FDA-approved antiviral drugs offers an effective route for treating Gulf War Illness and the symptoms. These findings were published in the journal, Viruses.

Learn more about the Gulf-War Illness:

Early studies have reported that exposure to chemicals have determined that chemical exposure from the Gulf War affected the balance between naturally occurring viruses and bacteria of the human GI tract and that this alteration results in the Gulf War Illness. Many of the symptoms largely include gastrointestinal disturbances, chronic fatigue and headaches along with respiratory/sleep problems and neurological implications in memory and learning processes. The illness has affected more than 200,000 Persian Gulf veterans over the last 30 years.

"Our own viruses interact with bacteria in the gut to maintain a healthy body and mind," says Saurabh Chatterjee, associate professor of environmental health sciences and director of the Environmental Health & Disease Laboratory, who led the study. "If we can tweak our own host viruses and their interactions with gut bacteria, then we can treat the disease symptoms of Gulf War Illness. With our most recent research, we have shown that antiviral drugs that are already in use can be a great starting point for curing the disease and helping thousands of veterans improve their quality of life."

Utilizing existing antiviral drugs can make the process easier by allowing clinicians to begin testing FDA-approved medications in clinical evaluations at an accelerated pace versus the lengthy timeline commonly seen in traditional pharmaceutical drug trials.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 15, 2019
Drug Discovery & Development
DEC 15, 2019
Promising Drug for Prostate Cancer
Using high-throughput screening methods, cancer researchers from the UK have identified some promising drug candidates to test thousands of molecules. Spec...
DEC 15, 2019
Drug Discovery & Development
DEC 15, 2019
AI Exponentially Accelerates Drug Development
Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial in...
DEC 15, 2019
Genetics & Genomics
DEC 15, 2019
Gates Foundation and NIH Pledge $200 Million for Gene Therapies in Africa
Over the next four years, the National Institutes of Health and the Bill and Melinda Gates Foundation plan to each invest $100 million towards the developm...
DEC 15, 2019
Microbiology
DEC 15, 2019
Antibody Discovered That May be the Key to a Universal Flu Vaccine
Instead of designing a new flu vaccine every year, researchers have made a breakthrough that may lead to a single vaccine that protects against all strains....
DEC 15, 2019
Cannabis Sciences
DEC 15, 2019
Cannabis Can't Simply Replace Opioids for Pain Management
According to the research, cannabis is not effective when it comes to treating individuals struggling with opioid use disorder. While some may have conside...
DEC 15, 2019
Drug Discovery & Development
DEC 15, 2019
Drug Candidates for Alzheimer Disease May Reverse Effects of Aging
Researchers using mouse models of Alzheimer disease were able to demonstrate that the investigational drug candidates ‘CMS121’ and ‘J147&...
Loading Comments...